The potential of soluble galectin-9 as a diagnostic biomarker is particularly significant because it can be detected without laparoscopic diagnostic surgery, a standard way endometriosis and other gynecologic disorders are currently being diagnosed. Here, LGALS9 is linked to endometriosis.